Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Revenue

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 13.61M in the quarter ending Mar 31, 2026, with -22.26%. This bring the company's revenue in the last twelve months to 42.19M, Decreased 0.43%. In the fiscal year ending Dec 31, 2025, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 42.01M with -41.46% growth.

Revenue (ttm)

42.19M

Revenue Growth

-40.81%

P/S Ratio

5.19

Revenue/Employee

zł196,304

Employees

214

Market Cap

zł218.18M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	42.01M	-29.75M	-41.46%
Dec 31, 2024	71.76M	13.15M	+22.44%
Dec 31, 2023	58.61M	8.22M	+16.32%
Dec 31, 2022	50.38M	9.23M	+22.43%
Dec 31, 2021	41.15M	995.00K	+2.48%
Dec 31, 2020	40.16M	1.05M	+2.69%
Dec 31, 2019	39.11M	6.81M	+21.10%
Dec 31, 2018	32.29M	889.00K	+2.83%
Dec 31, 2017	31.40M	―	―